Treatment of anaerobic infections with metronidazole

J. P. Rissing, W. L. Moore, C. Newman

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Metronidazole was used parenterally and orally to treat thirty patients with a variety of anaerobic and mixed infections. Other antimicrobial agents with activity against infecting anaerobes were not used or had failed. Sixteen patients (53%) were cured, thirteen (43%) were improved; and one (3%) failed to respond. Cultures during therapy disclosed no anaerobic pathogens in 24 of 26 (92%). Clinical failure (one patient) and the continuing presence of anaerobic pathogens (two patients) were associated with initially inadequate surgical procedures. Peak plasma levels achieved with doses of approximately 30 mg/kg/day in 26 patients were 21.0 ± 7.2 μg/ml. Slightly higher peak levels were achieved when this dose was preceded by a loading dose of 15 mg/kg. Side effects were infrequent and mild: pruritus with rash: 3 (10%); nausea: 5 (17%); and metallic taste: 2 (7%).

Original languageEnglish (US)
Pages (from-to)651-663
Number of pages13
JournalCurrent Therapeutic Research - Clinical and Experimental
Issue number5
StatePublished - Jan 1 1980

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Treatment of anaerobic infections with metronidazole'. Together they form a unique fingerprint.

Cite this